Armbrust, Tabea <br/><br/>
CXCL4L1 Promoter Polymorphisms Are Associated with Improved Renal Function in Type 1 Diabetes.  [electronic resource] 

 -  Journal of immunology (Baltimore, Md. : 1950)  02 2019 
 - 912-919 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1550-6606 
<br/><br/><label>Standard No.: </label>10.4049/jimmunol.1801086  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Diabetes Mellitus, Type 1--genetics<br/>Female<br/>Gene Expression<br/>Genotyping Techniques<br/>HEK293 Cells<br/>Humans<br/>Inflammation--genetics<br/>Interleukin-1--pharmacology<br/>Kidney--physiopathology<br/>Male<br/>Mesangial Cells--metabolism<br/>Middle Aged<br/>NF-KappaB Inhibitor alpha--metabolism<br/>Platelet Factor 4--genetics<br/>Polymorphism, Single Nucleotide<br/>Promoter Regions, Genetic<br/>Signal Transduction<br/>Smad7 Protein--metabolism<br/>Tumor Necrosis Factor-alpha--pharmacology